Document is current
Any future updates will be listed below
-
Authors
Sterke, F. https://orcid.org/0000-0002-7194-491X
van Weteringen, W. https://orcid.org/0000-0003-2667-3169
van der Zee, P. A. https://orcid.org/0000-0002-5577-6848
van Rosmalen, J. https://orcid.org/0000-0002-9187-244X
Wijnen, R. M. H. https://orcid.org/0000-0001-7266-9713
-
Funding
Funding for this research was provided by:
Health~Holland (LSHM17063)
Merck (ISS57163)
- License Information
-
More Information
Article History
Received: 6 July 2024
Accepted: 2 October 2024
First Online: 24 October 2024
Disclosures
: Erasmus MC received partial funding from Health ~ Holland (LSHM17063) and Merck Sharp & Dohme Corp (ISS57163). Erasmus MC holds patents on improved insufflation devices, with Willem van Weteringen, John Vlot, and Frank Sterke as inventors. John Vlot received an insufflation device from Karl Storz SE & Co. KG. Willem van Weteringen and Frank Sterke are partially employed by an Erasmus MC spin-off developing an enhanced insufflator. Philip van der Zee, Joost van Rosmalen, and René Wijnen have no conflicts of interest.
